Literature DB >> 26353976

Uterine Carcinomas in Tetrabromobisphenol A-exposed Wistar Han Rats Harbor Increased Tp53 Mutations and Mimic High-grade Type I Endometrial Carcinomas in Women.

Janice B Harvey1, Tanasa S Osborne2, Hue-Hua L Hong3, Sachin Bhusari3, Tai-Vu Ton3, Arun R Pandiri4, Tiwanda Masinde3, June Dunnick5, Shyamal Peddada6, Susan Elmore3, Mark J Hoenerhoff7.   

Abstract

Endometrial carcinoma is the most common gynecologic malignancy is the United States and accounts for 6% of all cancers in women. The disease is classified as type I or type II based on clinicopathologic and molecular features. It is a multifactorial disease with a number of risk factors, including environmental exposures. How environmental exposures, such as flame retardants, may affect the incidence of endometrial cancer is a topic of current and ongoing interest. Tetrabromobisphenol A (TBBPA) is a widely used brominated flame retardant found in a variety of household products. A recent 2-year National Toxicology Program carcinogenicity study found that exposure to TBBPA was associated with a marked increase in the development of uterine tumors, specifically uterine carcinomas, in Wistar Han rats. Molecularly, TBBPA-induced uterine carcinomas in Wistar Han rats were characterized by a marked increase in tumor protein 53 mutation compared to spontaneous uterine carcinomas, as well as overexpression of human epidermal growth factor receptor 2. Similar to spontaneous carcinomas, tumors in TBBPA-exposed rats were estrogen receptor-alpha positive and progesterone receptor negative by immunohistochemistry. The morphologic and molecular features of uterine carcinomas in TBBPA-exposed rats resemble those of high-grade type I tumors in women, and these data suggest that exposure to TBBPA may pose an increased cancer risk.
© 2015 by The Author(s).

Entities:  

Keywords:  Ccnd1; Cdh1; Ctnnb1; Her2; Kras; Tp53; Wistar Han rats; dometrial carcinoma; tetrabromobisphenol A

Mesh:

Substances:

Year:  2015        PMID: 26353976      PMCID: PMC4670270          DOI: 10.1177/0192623315599256

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  34 in total

Review 1.  p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect.

Authors:  M V Blagosklonny
Journal:  FASEB J       Date:  2000-10       Impact factor: 5.191

2.  p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.

Authors:  Y S Bian; M C Osterheld; F T Bosman; J Benhattar; C Fontolliet
Journal:  Mod Pathol       Date:  2001-05       Impact factor: 7.842

Review 3.  Molecular pathology of endometrial hyperplasia and carcinoma.

Authors:  X Matias-Guiu; L Catasus; E Bussaglia; H Lagarda; A Garcia; C Pons; J Muñoz; R Argüelles; P Machin; J Prat
Journal:  Hum Pathol       Date:  2001-06       Impact factor: 3.466

4.  Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation.

Authors:  B Modan; P Hartge; G Hirsh-Yechezkel; A Chetrit; F Lubin; U Beller; G Ben-Baruch; A Fishman; J Menczer; J P Struewing; M A Tucker; S Wacholder
Journal:  N Engl J Med       Date:  2001-07-26       Impact factor: 91.245

5.  High-density marker loss of heterozygosity analysis of rat chromosome 10 in endometrial adenocarcinoma.

Authors:  A Behboudi; G Levan; H J Hedrich; K Klinga-Levan
Journal:  Genes Chromosomes Cancer       Date:  2001-12       Impact factor: 5.006

6.  Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study.

Authors:  H B Salvesen; O E Iversen; L A Akslen
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

Review 7.  Hormonal interactions in endometrial cancer.

Authors:  G Emons; G Fleckenstein; B Hinney; A Huschmand; W Heyl
Journal:  Endocr Relat Cancer       Date:  2000-12       Impact factor: 5.678

8.  Interferon regulatory factor-1 expression in human uterine endometrial carcinoma.

Authors:  Haruo Kuroboshi; Tomoharu Okubo; Kotaro Kitaya; Takeshi Nakayama; Nobue Daikoku; Shinji Fushiki; Hideo Honjo
Journal:  Gynecol Oncol       Date:  2003-11       Impact factor: 5.482

Review 9.  Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.

Authors:  Sigurd F Lax
Journal:  Virchows Arch       Date:  2004-01-28       Impact factor: 4.064

Review 10.  Endometrial cancer: experimental models useful for studies on molecular aspects of endometrial cancer and carcinogenesis.

Authors:  G Vollmer
Journal:  Endocr Relat Cancer       Date:  2003-03       Impact factor: 5.678

View more
  3 in total

1.  Differential Receptor Tyrosine Kinase Phosphorylation in the Uterus of Rats Following Developmental Exposure to Tetrabromobisphenol A.

Authors:  Lysandra Castro; Jingli Liu; Linda Yu; Alanna D Burwell; Trey O Saddler; Lindsay A Santiago; William Xue; Julie F Foley; Michael Staup; Norris D Flagler; Min Shi; Linda S Birnbaum; Dixon Darlene
Journal:  Toxicol Res Appl       Date:  2021-11-18

2.  Mechanochemical conversion of brominated POPs into useful oxybromides: a greener approach.

Authors:  Giovanni Cagnetta; Han Liu; Kunlun Zhang; Jun Huang; Bin Wang; Shubo Deng; Yujue Wang; Gang Yu
Journal:  Sci Rep       Date:  2016-06-21       Impact factor: 4.379

3.  Derivation of a no-significant-risk-level for tetrabromobisphenol A based on a threshold non-mutagenic cancer mode of action.

Authors:  Alison M Pecquet; Jeanelle M Martinez; Melissa Vincent; Neeraja Erraguntla; Michael Dourson
Journal:  J Appl Toxicol       Date:  2018-02-13       Impact factor: 3.446

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.